4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000139
EVP, Chief Scientific Officer sold 3,231 shares at $490.00 ($1,583,190)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ALTSHULER DAVID · EVP, Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-03 | Sale : show line 1 in the form 10b5-1 | −3,231 | $490.00 | $1,583,190 | 29,743 | D |
| Open-market sales · 3,231 sh · avg $490.00 · $1,583,190 | ||||||
Loading xslF345X05/wk-form4_1741208889.xml…